PlainRecordsSufentanil Citrate Injection
On FDA's list as current shortage: 4 packages from 2 companies. Last updated by FDA Nov. 9, 2026. Data from openFDA as of Nov. 12, 2026; FDA's own database can be newer. Not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.
3 of 4 packages on FDA's current shortage list are listed as unavailable; 1 limited, 0 available.
Reason FDA gives most often: “Other” (4 of 4). Check with your pharmacy: FDA's list is national.Current shortage (4)
● available · ◐ limited · ○ unavailable
| Strength | Companies and FDA's availability |
|---|---|
| 50 mcg/mL | ◐ Hospira, Inc., a Pfizer Company, limited○ Hikma Pharmaceuticals USA, Inc.×3, unavailable |
Each chip is a company as FDA names it, marked with FDA's availability value for its packages of that strength (×N: N packages; point at a chip for FDA's package texts). Strengths are read from FDA's package text, one row an amount ("10 mg/1 mL" and "50 mg/5 mL (10 mg/mL)" are one row, 10 mg/mL), in the unit FDA wrote; where FDA gives only an amount per volume, the amount per mL is worked out ("5 g/100 mL" is 50 mg/mL); the package sizes are listed under each strength.
By company: availability, FDA's notes and contact
Hikma Pharmaceuticals USA, Inc.
3 packages: 3 unavailable · contact 800-631-2174
Reason “Other”
FDA's note “Not currently manufactured”
Hospira, Inc., a Pfizer Company
1 package: 1 limited · contact 844-646-4398
Reason “Other”
FDA's note “Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay”
Every entry as FDA lists it (4)
Current shortage (4)
Hikma Pharmaceuticals USA, Inc.
Contact: 800-631-2174
- UnavailableSufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)Reason: Other
Related information: Not currently manufactured
First posted May 3, 2022 · updated Oct. 14, 2026 - UnavailableSufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)Reason: Other
Related information: Not currently manufactured
First posted May 3, 2022 · updated Oct. 14, 2026 - UnavailableSufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)Reason: Other
Related information: Not currently manufactured
First posted May 3, 2022 · updated Oct. 14, 2026
Hospira, Inc., a Pfizer Company
Contact: 844-646-4398
- Limited AvailabilitySufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)Reason: Other
Related information: Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
First posted May 3, 2022 · updated Nov. 9, 2026
Data provided by the U.S. Food and Drug Administration through openFDA, as of Nov. 12, 2026; FDA's drug shortage database can be newer. openFDA's own note on this data: "Do not rely on openFDA to make decisions regarding medical care." This is not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.